In a single-center retrospective study of the genomic landscape of 185 glioblastoma patients, multivariate analysis controlling for 6 covariates with known impact on survival while accounting for multiple gene comparisons revealed that CDKN2B, EGFR, and PTEN mutations were independently associated with survival. Here, CDKN2B is linked to glioblastoma.